Utshintsho luqhubela phambili inkqubela.Xa kuziwa kubutsha kuphuhliso lwamachiza amatsha kunye neemveliso zonyango lwebhayoloji, Iziko le-FDA loVavanyo lweZiyobisi kunye noPhando (CDER) lixhasa ishishini loxubo mayeza kuwo onke amanqanaba enkqubo.Ngokuqonda kwayo isayensi esetyenziselwa ukudala iimveliso ezintsha, ukuvavanya kunye neenkqubo zokuvelisa, kunye nezifo kunye neemeko ezilungiselelwe ukunyanga iimveliso ezintsha, i-CDER ibonelela ngeengcebiso zenzululwazi kunye nokulawula ezifunekayo ukuzisa unyango olutsha kwiimarike.
Ubukho bamachiza amatsha kunye neemveliso zebhayoloji zihlala zithetha iindlela ezintsha zonyango lwezigulane kunye nenkqubela phambili yokhathalelo lwempilo kuluntu lwaseMelika.Ngesi sizathu, i-CDER ixhasa ukusungula izinto ezintsha kwaye idlala indima ephambili ekuncedeni ukuqhubela phambili uphuhliso lwamachiza amatsha.
Nyaka ngamnye, i-CDER ivuma uluhlu olubanzi lwamachiza amatsha kunye neemveliso zebhayoloji:
1. Ezinye zezi mveliso ziimveliso ezintsha ezingazange zisetyenziswe kwiklinikhi.Apha ngezantsi kukho uluhlu lwamaqumrhu amatsha emolekyuli kunye neemveliso ezintsha zonyango zebhayoloji ezivunywe yi-CDER ngo-2021. Olu luhlu aluqukethe izitofu, iimveliso ze-allergenic, igazi kunye neemveliso zegazi, i-plasma derivatives, i-cellular kunye ne-gene therapy iimveliso, okanye ezinye iimveliso ezivunyiweyo ngo-2021 ngu. Iziko loVavanyo lweBiologics kunye noPhando.
2. Ezinye ziyafana, okanye zihlobene, neemveliso ezivunyiweyo ngaphambili, kwaye ziya kukhuphisana nezo mveliso kwindawo yentengiso.Jonga Drugs@FDA ngolwazi malunga nawo onke amachiza avunyiweyo e-CDER kunye neemveliso zebhayoloji.
Amachiza athile ahlelwa njengamaqumrhu amatsha emolekyuli ("NMEs") ngeenjongo zokuphononongwa kwe-FDA.Uninzi lwezi mveliso ziqulethe iimoieties ezisebenzayo ezingavunywanga yi-FDA ngaphambili, nokuba sisithako esinye sechiza okanye njengenxalenye yemveliso edibeneyo;ezi mveliso zihlala zibonelela ngonyango olutsha olubalulekileyo kwizigulana.Amanye amachiza abonakaliswe njenge-NMEs ngeenjongo zolawulo, kodwa nangona kunjalo aqulathe i-moieties esebenzayo esondeleleneyo ne-moieties esebenzayo kwiimveliso ezivunywe ngaphambili yi-FDA.Umzekelo, i-CDER ihlela iimveliso zebhayoloji ezifakwe kwisicelo phantsi kwecandelo lama-351 (a) loMthetho weNkonzo yezeMpilo kaRhulumente njengee-NME ngeenjongo zokuphononongwa kwe-FDA, nokuba i-Arhente ivume ngaphambili i-moiety esebenzayo enxulumeneyo kwimveliso eyahlukileyo.Ukuhlelwa kwechiza kwe-FDA njenge "NME" ngeenjongo zokuphonononga kwahlukile kwisigqibo se-FDA sokuba ingaba imveliso yechiza "liqumrhu elitsha lekhemikhali" okanye "NCE" ngaphakathi kwentsingiselo yoMthetho woKutya, iChiza, kunye neCosmetic.
Hayi. | Igama leziyobisi | Isithako esisebenzayo | Umhla wokuvunywa | Usetyenziso oluvunywe yi-FDA ngomhla wokuvunywa* |
37 | Exkivity | mobocertinib | 9/15/2021 | Ukunyanga umhlaza wemiphunga we-epidermal ophucukileyo wasekhaya okanye we-metastatic ongengowomncinci kunye ne-epidermal growth factor receptor exon 20 efakelwayo utshintsho |
36 | Skytrofa | lonapegsomatropin-tcgd | 8/25/2021 | Ukunyanga ubude obufutshane ngenxa yokungakhuseli ngokwaneleyo kwehomoni yokukhula engapheliyo |
35 | Korsuva | iflikefalin | 8/23/2021 | Ukunyanga i-pruritus ephakathi ukuya kweyobunzima ehambelana nesifo sezintso ezingapheliyo kubantu abathile |
34 | Welireg | ibelzutifan | 8/13/2021 | Ukunyanga isifo se-von Hippel-Lindau phantsi kweemeko ezithile |
33 | Nexviazyme | i-avalglucosidase alfa-ngpt | 8/6/2021 | Ukunyanga isifo sePompe emva kwexesha |
Upapasho ndaba zekhampani | ||||
32 | Saphnelo | anifrolumab-fnia | 7/30/2021 | Ukunyanga i-systemic lupus erythematousus ephakathi ukuya kobunzima kunye nonyango oluqhelekileyo |
31 | Bylvay | odevixibat | 7/20/2021 | Ukunyanga i-pruritus |
30 | Rezurock | belumosudil | 7/16/2021 | Ukunyanga isifo esinganyangekiyo sokuxhunyelelwa-kunye-nomkhosi emva kokusilela ubuncinci kwimigca emibini yangaphambili yonyango lwenkqubo |
29 | fexidazole | fexidazole | 7/16/2021 | Ukunyanga itrypanosomiasis yabantu baseAfrika ebangelwa yi-parasite Trypanosoma brucei gambinse |
28 | Kerendia | finerenone | 7/9/2021 | Ukunciphisa umngcipheko weentso kunye neengxaki zentliziyo kwisifo esingapheliyo sesifo esinxulumene nesifo seswekile se-2 |
27 | Rylaze | i-asparaginase erwinia chrysanthemi (i-recombinant) -rywn | 6/30/2021 | Ukunyanga i-acute lymphoblastic leukemia kunye ne-lymphoblastic lymphoma kwizigulana ezingadibaniyo ne-E. coli-derived asparaginase iimveliso, njengenxalenye yerejimeni yechemotherapy |
Upapasho ndaba zekhampani | ||||
26 | Aduhelm | aducanumab-avwa | 6/7/2021 | Ukunyanga isifo sika-Alzheimer |
Upapasho ndaba zekhampani | ||||
25 | Brexafemme | ibrexafungerp | 6/1/2021 | Ukunyanga i-vulvovaginal candidiasis |
24 | Lybalvi | i-olanzapine kunye ne-samidorphan | 5/28/2021 | Ukunyanga i-schizophrenia kunye nemiba ethile ye-bipolar I disorder |
23 | Truseltiq | infigratinib | 5/28/2021 | Ukunyanga i-cholangiocarcinoma enesifo esihlangabezana neekhrayitheriya ezithile |
22 | Lumakras | sotorasib | 5/28/2021 | Ukunyanga iintlobo zomhlaza wemiphunga weseli engeyiyo encinci |
Upapasho ndaba zekhampani | ||||
21 | I-Pylarify | ipiflufolastat F18 | 5/26/2021 | Ukuchonga izilonda ze-prostate-specific membrane antigen-positive kumhlaza we-prostate |
20 | Rybrevant | amivantamab-vmjw | 5/21/2021 | Ukunyanga iseti yomhlaza wemiphunga yeseli engeyiyo encinci |
Upapasho ndaba zekhampani | ||||
19 | Empaveli | pegcetacoplan | 5/14/2021 | Ukunyanga i-paroxysmal nocturnal hemoglobinuria |
18 | Zynlonta | loncastuximab tesirine-lpyl | 4/23/2021 | Ukunyanga iintlobo ezithile ze-lymphoma ephindaphindayo okanye i-refractory enkulu ye-B-cell lymphoma |
17 | Jemperli | dostarlimab-gxly | 4/22/2021 | Ukunyanga umhlaza we-endometrial |
Upapasho ndaba zekhampani | ||||
16 | Ezilandelayo | drospirenone kunye ne estetrol | 4/15/2021 | Ukuthintela ukukhulelwa |
15 | Qelbree | viloxazine | 4/2/2021 | Ukunyanga ukunqongophala kwengxaki yokungasebenzi kakuhle |
14 | Zegalogue | i-dasiglucagon | 3/22/2021 | Ukunyanga i-hypoglycemia enzima |
13 | Iponvory | ponesimod | 3/18/2021 | Ukunyanga iindlela ezibuyela umva zemultiple sclerosis |
12 | Fotivda | tivozanib | 3/10/2021 | Ukunyanga i-renal cell carcinoma |
11 | Azstarys | serdexmethylphenidate kunye | 3/2/2021 | Ukunyanga ukunqongophala kwengxaki yokungasebenzi kakuhle |
dexmethylphenidate | ||||
10 | Pepaxto | melphalan flufenamide | 2/26/2021 | Ukunyanga i-myeloma ephindaphindiweyo okanye echasayo |
9 | Nulibry | fosdenopteri | 2/26/2021 | Ukunciphisa umngcipheko wokusweleka kwi-molybdenum cofactor yokusilela udidi A |
Upapasho ndaba zekhampani | ||||
8 | IiAmonds 45 | casimersen | 2/25/2021 | Ukunyanga iDuchenne muscular dystrophy |
Upapasho ndaba zekhampani | ||||
7 | Cosela | trilacicilib | 2/12/2021 | Ukunciphisa ichemotherapy-induced myelosuppression kumhlaza wemiphunga omncinci weseli |
Upapasho ndaba zekhampani | ||||
6 | Evkeeza | evinacumab-dgnb | 2/11/2021 | Ukunyanga i-homozygous yosapho lwe-hypercholesterolemia |
5 | Ukoniq | umbralisib | 2/5/2021 | Ukunyanga i-lymphoma ye-marginal zone kunye ne-follicular lymphoma |
4 | Tepmetko | itepotinib | 2/3/2021 | Ukunyanga umhlaza wemiphunga weseli ongemncinci |
3 | Lupkynis | iVoclosporin | 1/22/2021 | Ukunyanga i-lupus nephritis |
Iimvavanyo zeziyobisi Isifinyezo | ||||
2 | Cabenuva | I-cabotegravir kunye ne-rilpivirine (zipakishwe kunye) | 1/21/2021 | Ukunyanga i-HIV |
Upapasho ndaba zekhampani | ||||
Iimvavanyo zeziyobisi Isifinyezo | ||||
1 | Verquvo | vericiguat | 1/19/2021 | Ukunciphisa umngcipheko wokufa kwentliziyo kunye nokulaliswa esibhedlele ngenxa yokungaphumeleli kwentliziyo |
Iimvavanyo zeziyobisi Isifinyezo |
Uluhlu "losetyenziso oluvunyiweyo lwe-FDA" kule webhusayithi yenzelwe iinjongo zokubonisa kuphela.Ukubona iimeko zokusetyenziswa ezivunyiweyo ze-FDA [umzekelo, izalathisi, (s), abantu), irejimeni yedosi (s)] nganye kwezi mveliso, jonga olona lwazi lwamva nje oluvunyiweyo lwe-FDA.
Caphula kwiwebhusayithi ye-FDA:https://www.fda.gov/drugs/new-drugs-fda-cders-new-molecular-entities-and-new-therapeutic-biological-products/novel-drug-approvals-2021
Ixesha lokuposa: Sep-27-2021